Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC
Clinical trial NCT05092412 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05092412
- Sponsor
- You Lu
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-02
- Primary completion
- 2023-02-06
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.